Research final exam PHA 309

Descripción

1 Pharmacy Test sobre Research final exam PHA 309, creado por TUAN TRAN el 07/10/2017.
TUAN TRAN
Test por TUAN TRAN, actualizado hace más de 1 año
TUAN TRAN
Creado por TUAN TRAN hace más de 6 años
7
1

Resumen del Recurso

Pregunta 1

Pregunta
Which of the following are Primary Literature are primary literatures:
Respuesta
  • Clinical trial
  • Pharmaceutical research
  • Educational assessment
  • Drug references (micromedex,Lexicomp)
  • Review articles
  • Clinical practice guidelines
  • Cohort studies

Pregunta 2

Pregunta
Pubmed is a tertiary source.
Respuesta
  • True
  • False

Pregunta 3

Pregunta
Case series and case reports are
Respuesta
  • Primary
  • Tertiary
  • Secondary

Pregunta 4

Pregunta
Which of the followings belong to Experimental studies.
Respuesta
  • Cohort
  • Educational assesment
  • Clinical trial
  • Cross-sectional
  • Case control
  • Pharmaceutical research

Pregunta 5

Pregunta
Observational studies includes
Respuesta
  • Clinical trial
  • Pharmaceutical research
  • Case control
  • Cohort
  • Cross-sectional

Pregunta 6

Pregunta
Prescription drug spending is one of its fastest growing components, increasing at double-digit rates in Health care spending each of the past 7 years.
Respuesta
  • True
  • False

Pregunta 7

Pregunta
There are several components to this rapid rise in spending of Prescription drugs:
Respuesta
  • more prescriptions are being written
  • prices of existing drugs are rising
  • higher-priced new drugs are replacing existing drugs
  • More drug manufactures are on the market.
  • More Pharmacist students graduated.

Pregunta 8

Pregunta
IN pre-clinical trial, ____________ is preferred.
Respuesta
  • Intent to treat
  • Per-protocol

Pregunta 9

Pregunta
In clinical trial phase, in order to measure safety and effectiveness, _____________ is preferred.
Respuesta
  • Intent to treat
  • Per protocol

Pregunta 10

Pregunta
Literature review should be accurate and balanced in Introduction.
Respuesta
  • True
  • False

Pregunta 11

Pregunta
In __________, missing data is filled with the last data
Respuesta
  • Extreme case analysis.
  • LOCF.
  • Complete case analysis.

Pregunta 12

Pregunta
In ______________, patient in the drug group is being given the worst data while patient in placebo group is being given
Respuesta
  • Complete case analysis
  • Extreme case analysis
  • LOCF

Pregunta 13

Pregunta
In __________, if data is missing, patient in drug group will be given the best data.
Respuesta
  • Extreme case analysis
  • Complete case analysis
  • LOCF

Pregunta 14

Pregunta
Randomization will limit selection bias.
Respuesta
  • True
  • False

Pregunta 15

Pregunta
Three things to look for regarding to safety.
Respuesta
  • Adverse effects
  • Common effects
  • Number of people drop out due to adverse drug events
  • Number of patient attend the trial

Pregunta 16

Pregunta
DCTA is promotional advertising of pharmaceutical products directly to consumers vias:
Respuesta
  • Facebook
  • Magazine & newspapers ads
  • product placement
  • Web sites & other internet sites.
  • Referral program.
  • Trials.

Pregunta 17

Pregunta
DCTA is defined as good education for patients that doesn't influence providers' prescribing practices.
Respuesta
  • True
  • False

Pregunta 18

Pregunta
Pharmaceutical manufacturers use several types of promotions. They are
Respuesta
  • Detailings (29% of spending)
  • Sampling (55% of spending)
  • Direct to consumer (DTC) advertising (14% of spending)
  • None of these above.

Pregunta 19

Pregunta
The drugs most heavily promoted to both consumers and physicians are typical drugs that treat acute conditions.
Respuesta
  • True
  • False

Pregunta 20

Pregunta
If the FDA approves a drug, it must be safe
Respuesta
  • True
  • False

Pregunta 21

Pregunta
If a drug is effective, it works for every one.
Respuesta
  • True
  • False

Pregunta 22

Pregunta
If a famous doctor recommends this drug, it must be good
Respuesta
  • True
  • False

Pregunta 23

Pregunta
product claims ads definition is
Respuesta
  • These name a drug and the condition it treats, and talk about both its benefits and risks
  • They give the drug's name, but not the drug's uses.
  • These describe a disease or condition, but don't recommend or suggest specific drugs.

Pregunta 24

Pregunta
Reminder ads definition is
Respuesta
  • These name a drug and the condition it treats, and talk about both its benefits and risks
  • They give the drug's name, but not the drug's uses.
  • These describe a disease or condition, but don't recommend or suggest specific drugs.

Pregunta 25

Pregunta
Help-seeking ads definition is
Respuesta
  • These name a drug and the condition it treats, and talk about both its benefits and risks
  • They give the drug's name, but not the drug's uses.
  • These describe a disease or condition, but don't recommend or suggest specific drugs.

Pregunta 26

Pregunta
DTCA practices have multiple impacts
Respuesta
  • Health impact
  • Economic impact
  • Image impact
  • Social life impact
  • Law impact

Pregunta 27

Pregunta
DCTA raises concerns by
Respuesta
  • Increasing OTC drugs' prices
  • Increasing prescription costs
  • Misleading statements lead to irractional use and undue risks
  • Often breaches regulation
  • Strains on physicians-patient relation
  • No evidence of health benefits
  • Decreasing prescription costs

Pregunta 28

Pregunta
DTC advertising is the primary driver of growth in prescription drug spending
Respuesta
  • True
  • False

Pregunta 29

Pregunta
___________ should fairly represent the study design, objective, methods, and result.
Respuesta
  • Abstract
  • Introdution
  • Conclusion
  • Method

Pregunta 30

Pregunta
Literature review should be accurate and balanced in ______
Respuesta
  • Introduction
  • Method
  • Conclusion
  • Evaluation

Pregunta 31

Pregunta
In Method, the design of method should
Respuesta
  • Show safety
  • Address study objective
  • Allow for support or rejection of null hypothesis
  • Use appropriate analysis (intent to treat or per-protocol)
  • Not address study objective
  • only use per-protocol approach
Mostrar resumen completo Ocultar resumen completo

Similar

PHARMACOLOGY BLOCK 1- basic intro
wallacejr@hotmail.co
PUBLIC HEALTH
Zinab Keshk
Exam 1 Medications
tera_alise
Introduction to pharmacology
Ifeoma Ezepue
Drug receptor interactions
Ifeoma Ezepue
Pharmacology II-III
Gwen Paparone
Pharmacology Chap 10 & 11
Robin Gatson
Monoamine pharmacology -Antidepressant drugs - Dr. Emma Robinson
Anna mph
pharmacology chapter 8 and 20
Alannah Mendoza
module 4 chapter 19
Alannah Mendoza